Emergence of lung cancer with a low PD-L1 expression level after the administration of immune check point inhibitor for lung adenocarcinoma with a high PD-L1 expression level: A case report

BACKGROUND: Checkpoint therapy against PD-1 has proven effective and positive results have been observed in several types of cancer, including lung cancer, renal cancer, lymphoma and melanoma. However, the effects of long-term ICI treatment remain insufficient and the development of resistance is an...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwai, Shun, Funasaki, Aika, Sekimura, Atsushi, Motono, Nozomu, Usuda, Katsuo, Yamada, Sohsuke, Ueda, Yoshimichi, Akasaki, Kyouta, Tanimura, Kouta, Kase, Kazumasa, Uramoto, Hidetaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320235/
https://www.ncbi.nlm.nih.gov/pubmed/32612822
http://dx.doi.org/10.1016/j.amsu.2020.05.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320235/
https://www.ncbi.nlm.nih.gov/pubmed/32612822
http://dx.doi.org/10.1016/j.amsu.2020.05.021

Ejemplares similares